New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Filgrastim Biosimilars Global Market Report 2023" - https://www.reportlinker.com/p06241850/?utm_source=GNW, Biocon and Aryogen Biopharma. The filgrastim biosimilars market is expected to reach $1.19 billion in 2026 at a CAGR of 8.0%. The regions covered in the filgrastim biosimilars market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the filgrastim biosimilars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The filgrastim biosimilars market research report is one of a series of new reports that provides filgrastim biosimilars market statistics, including filgrastim biosimilars industry global market size, regional shares, competitors with a filgrastim biosimilars market share, detailed filgrastim biosimilars market segments, market trends and opportunities, and any further data you may need to thrive in the filgrastim biosimilars industry.
Continue reading...